Skip to search formSkip to main contentSkip to account menu

Ritanserin

Known as: 5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-(bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-, Ritanserin [Chemical/Ingredient], 6-(2-(4-(Bis(P-Fluorophenyl)Methylene)-Piperidino)Ethyl)-7-Methyl-5h-Thiazolo-(3,2-A)Pyrimidin-5-One 
A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
The effect of 5-HT2 receptor blocker ritanserine on the analgesic effect of morphine was studied in experiments on mice. A single… 
1997
1997
During embryogenesis, serotonin has been reported to be involved in craniofacial and cardiovascular morphogenesis. The detailed… 
1997
1997
The effect of 5-HT2 receptor blocker ritanserine on the analgesic effect of morphine was studied in experiments on mice. A single… 
1996
1996
A strong relationship was previously described between the nocturnal oscillations of plasma renin activity (PRA) and the sleep… 
1992
1992
To the Editor. —Several agents directed at neurotransmitter control of corticotropin secretion, such as cyproheptadine… 
1992
1992
Abstract Ritanserin has been reported to be a potential antiarrhythmic. We studied the cellular electrophysiologic effects of… 
1989
1989
The influence of age on the regional arterial and venous effects of serotonin (5-HT) was investigated in 13 young (aged 22–31… 
1987
1987
Ritanserin, a new serotonin antagonist selective upon S2 receptor subclass is available. Thus, in order to better define the… 
1987
1987
Since previously described simple methods were too insensitive to quantify the extent of microvascular permeability increase in… 
1985
1985
In the spontaneously hypertensive rat (SHR), ketanserin and the ketanserin analogues R56413 and ritanserin were studied with…